Interaction Propensity

Across disease status

How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.

5 groups · 7058 samples · 55 datasets

Group	Median	Samples
Primary cancer	1.21-1.664	6,024
Non-cancer disease	1.1331-1.5	209
Unspecified	1.1280-1.871	21
Metastatic cancer	1.1261-1.488	339
Healthy/control	1.1251-1.447	465

Across organs

How the same metric changes across tissue contexts after the current filters and tier are applied.

8 groups · 7058 samples · 55 datasets

Group	Median	Samples
Head and neck	1.6621.356-2.22	92
Heart	1.3791.081-2	1
Adrenal gland	1.3661.086-2.113	17
Musculoskeletal	1.3461.189-1.679	1
Lung	1.331-1.81	2,783
Kidney	1.331.056-1.709	25
Lymphoid tissue	1.2911.109-1.702	142
Pancreas	1.2751.013-1.667	86

Disease status x organ

The combined comparison, useful for separating disease effects from tissue composition.

10 groups · 7058 samples · 55 datasets

Group	Median	Samples
Unspecified x Skin	1.751-5.354	18
Healthy/control x Brain	1.7261.244-2.529	3
Primary cancer x Head and neck	1.6621.356-2.22	92
Metastatic cancer x Skin	1.4841.143-2.152	29
Primary cancer x Lymphoid tissue and lymphoma	1.4431.231-2.006	75
Healthy/control x Heart	1.3791.081-2	1
Primary cancer x Adrenal gland	1.3661.086-2.113	17
Healthy/control x Femur Bone	1.3461.189-1.679	1
Primary cancer x Lung	1.3331-1.788	2,741
Non-cancer disease x Kidney	1.331.056-1.709	25